Marine Fish Skin as Grafts

A special issue of Marine Drugs (ISSN 1660-3397).

Deadline for manuscript submissions: closed (30 November 2021) | Viewed by 366

Special Issue Editor


E-Mail Website
Guest Editor
Division of Vascular Surgery, Department of Surgery, The Icahn School of Medicine at Mount Sinai, New York, NY, USA
Interests: wound healing; tissue repair; vascular surgery; fish skin grafts; clinical trial

Special Issue Information

Dear Colleagues,

Over the last three decades, there has been an exponential growth in the number of non-autogenous derived skin grafts. A large number of these products are xenografts; the most recent addition to the non-human sourced grafts have been fish derived. The most widely used fish skin graft is derived from the North Atlantic cod. This marine-animal-derived skin is finding wide utility in the treatment of chronic wounds such as diabetic foot, venous leg ulcer and chronic autoimmune wounds. It is also being increasingly used in acute wounds such as burns and post surgical dehiscence. We have dedicated this edition to the research of the basic and clinical science supporting the use of marine animal derived skin for the modulation and closure of chronic and acute wounds.

Prof. Dr. John Carlos Lantis
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Fish skin
  • Diabetic foot
  • Venous leg ulcer
  • Autoimmune wounds
  • Burn wounds
  • Xenograft
  • Wound modulation
  • Wound healing

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop